Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lupin Pharmaceuticals has received tentative approval from the FDA for sertraline hydrochloride tablets, a generic version of Pfizer's depression drug Zoloft.
Subscribe to our email newsletter
Lupin Pharmaceuticals, a US subsidiary of Indian-based Lupin Limited, said that final approval is expected upon the expiration of the first abbreviated new drug application filer’s 180-day marketing exclusivity in February 2007.
Lupin’s sertraline tablets will be the AB-rated generic equivalent of Zoloft, which had annual sales of approximately $3.1 billion for the twelve months ended July 2006, based on IMS sales data.